Quest Diagnostics (DGX) Debt to Equity (2009 - 2026)

Quest Diagnostics has disclosed Debt to Equity across 18 years of filings, most recently posting $0.74 for Q1 2026.

• Debt to Equity for Q1 2026 came in at $0.74, down 12.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $0.74 (down 12.3% YoY), and the FY2025 annual result was $0.79, down 13.32% from the prior year.
• Debt to Equity came in at $0.74 for Q1 2026 at Quest Diagnostics, down from $0.79 in the prior quarter.
• In the past five years, Debt to Equity ranged from a high of $0.91 in Q3 2024 to a low of $0.62 in Q2 2022.
• The 5-year median for Debt to Equity is $0.73 (2024), against an average of $0.73.
• Across the five-year window, Debt to Equity soared 38.96% in 2024 and slipped 14.43% in 2025, its largest moves.
• Quest Diagnostics' Debt to Equity stood at $0.67 in 2022, then gained by 10.72% to $0.74 in 2023, then climbed by 22.79% to $0.91 in 2024, then declined by 13.32% to $0.79 in 2025, then declined by 6.68% to $0.74 in 2026.
• The last three Debt to Equity figures came in at $0.74 (Q1 2026), $0.79 (Q4 2025), and $0.78 (Q3 2025), per Business Quant data.